OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Genentech plans to invest more than $125 million in an expansion of its fill/finish facility in Hillsboro, OR.
Genentech announced on March 26, 2015 that it would invest more than $125 million in an expansion of its fill/finish facility in Hillsboro, OR. The fill/finish facility, which opened in April 2010, is currently home to warehousing and distribution. An increased demand for sterile products in Genentech’s pipeline necessitated an expansion to include the capacity for manufacturing, the company reports.
"This investment in our sterile production operations will result in the addition of up to 100 new skilled manufacturing jobs in the greater Portland area over the next five years, potentially bringing the total number of Genentech jobs in Oregon to over 500," said Larry Sanders, general manager and vice president, Hillsboro Technical Operations, in a press release.